Endo International plc – (ENDP) Short Interest Update

Endo International plc – (NASDAQ:ENDP) (TSE:ENL) was the target of a large decrease in short interest during the month of December. As of December 29th, there was short interest totalling 20,250,569 shares, a decrease of 13.5% from the December 15th total of 23,402,027 shares. Based on an average daily volume of 3,647,667 shares, the short-interest ratio is currently 5.6 days. Currently, 10.1% of the shares of the stock are short sold.

Shares of Endo International (ENDP) opened at $7.95 on Tuesday. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 10.78. The stock has a market cap of $1,780.00, a PE ratio of -0.41, a PEG ratio of 2.73 and a beta of 0.59. Endo International has a 1 year low of $5.77 and a 1 year high of $14.45.

Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Thursday, November 9th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.06. The firm had revenue of $786.90 million for the quarter, compared to analysts’ expectations of $794.93 million. Endo International had a negative net margin of 126.97% and a positive return on equity of 66.98%. The business’s revenue was down 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.01 EPS. sell-side analysts anticipate that Endo International will post 3.67 earnings per share for the current fiscal year.

Several research analysts have commented on the stock. Zacks Investment Research downgraded shares of Endo International from a “hold” rating to a “sell” rating in a report on Monday. Cantor Fitzgerald dropped their price objective on shares of Endo International from $9.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, November 10th. BidaskClub raised shares of Endo International from a “sell” rating to a “hold” rating in a report on Tuesday, December 12th. Citigroup dropped their price objective on shares of Endo International from $9.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, November 10th. Finally, BMO Capital Markets dropped their price objective on shares of Endo International from $11.00 to $10.00 and set a “market perform” rating for the company in a report on Friday, November 10th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $11.27.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. LMR Partners LLP purchased a new stake in Endo International in the 3rd quarter worth about $148,000. Riverhead Capital Management LLC raised its position in Endo International by 64.4% in the 2nd quarter. Riverhead Capital Management LLC now owns 15,025 shares of the company’s stock worth $168,000 after purchasing an additional 5,887 shares during the period. Bank of Hawaii purchased a new stake in Endo International in the 2nd quarter worth about $180,000. Flinton Capital Management LLC raised its position in Endo International by 64.4% in the 2nd quarter. Flinton Capital Management LLC now owns 20,400 shares of the company’s stock worth $228,000 after purchasing an additional 7,990 shares during the period. Finally, Nisa Investment Advisors LLC purchased a new stake in Endo International in the 4th quarter worth about $236,000. Hedge funds and other institutional investors own 93.06% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Endo International plc – (ENDP) Short Interest Update” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/3140410/endo-international-plc-endp-short-interest-update.html.

About Endo International

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.